Skip to main content
FORZ logo

Forza Innovations Inc. (FORZ) Stock Price & Analysis

Educational signal · not a buy or sell recommendation · How to read this

$0.0001 $0.00 (0.00%)
Vol: 3.00M| 52-wk range: $0.0001 – $0.0001

Beta 0.83: the stock has moved about 17% less than the S&P 500.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 13, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

Forza Innovations Inc. (FORZ) trades at $0.0001. Forza Innovations Inc. operates in the health-tech wearable performance sector, offering its WarmUp series of back compression devices. Sector: Healthcare.

Price as of · Last analyzed: Jun 13, 2026
Forza Innovations Inc. operates in the health-tech wearable performance sector, offering its WarmUp series of back compression devices. The company focuses on products designed to relax, warm up, loosen, or alleviate stiff and sore muscles.

Analyst Coverage for FORZ: FORZ does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.

▶ Watch the FORZ film Every key number, told as a short cinematic story — just press play. ~2 min

No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.

Forza Innovations Inc. (FORZ) Healthcare & Pipeline Overview

CEOEvan Schick
Employees2
HeadquartersSan Diego, US
IPO Year2019

Forza Innovations Inc. (FORZ) is a San Diego-based health-tech company specializing in wearable performance devices, specifically the WarmUp series of back compression products. Incorporated in 2014, the company's offerings, including the J4 Sport, J4 X, and J4 Fitbelt, are designed to address muscle stiffness and soreness, positioning it within the niche market of therapeutic wearables.

Data Provenance | Financial Data Quantitative Analysis Analysis: Jun 13, 2026

What Is the Investment Thesis for FORZ?

AI-written as of Jun 13, 2026 — figures and tone reflect the data available then, not today's score.

Forza Innovations Inc. operates in the health-tech wearable performance segment, offering its WarmUp series of back compression devices designed for muscle relaxation and recovery. The company's gross margin of 76.5% indicates strong product-level profitability, suggesting efficient cost management relative to its revenue stream. However, a significant profit margin of -4150.0% highlights substantial operational expenses or limited revenue generation, leading to considerable net losses. The beta of 0.83 suggests lower volatility compared to the broader market, which might appeal to certain investor profiles. Key growth catalysts could stem from increased adoption of wearable health technologies and a growing consumer focus on non-pharmacological pain and stiffness relief. The market for therapeutic wearables continues to expand, driven by aging populations and increased athletic participation. Value drivers include potential product line expansion within the wearable health space and enhanced market penetration for its existing WarmUp series. Risks include its current lack of profitability, small operational scale with only two employees, and the competitive landscape of the medical device and consumer health sectors. The company's ability to scale operations and achieve positive net income will be critical for long-term viability and investor returns.

Based on FMP financials and quantitative analysis

FORZ Key Highlights

AI-written as of Jun 13, 2026 — figures and tone reflect the data available then, not today's score.

Gross Margin of 76.5% indicates strong product-level profitability.

  • Profit Margin of -4150.0% reflects significant operational losses relative to revenue.
  • Market Capitalization is $0.00B, suggesting a micro-cap or pre-revenue stage.
  • Beta of 0.83 indicates lower stock price volatility compared to the overall market.
  • Operates with a lean team of 2 employees, highlighting a highly focused or early-stage operational structure.

Who Are FORZ's Competitors?

FORZ is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
BJDX Bluejay Diagnostics, Inc. $0.84 -1.12% 30 5-pillar
NVNO enVVeno Medical Corporation $8.10 +0.75% $5.63M 33 5-pillar
BDMD Baird Medical Investment Holdings Limited $0.75 +0.91% $31.7M —
SNWV SANUWAVE Health, Inc. $4.82 +4.33% $41.5M 36 5-pillar
SRTS Sensus Healthcare, Inc. $2.98 +1.02% $49.1M 31 5-pillar
HYPD Hyperion DeFi, Inc. $3.73 +1.91% $56.5M 36 5-pillar
LNSR LENSAR, Inc. $6.75 +2.74% $82.9M 45 5-pillar
APYX Apyx Medical Corporation $2.55 +2.00% $107M 33 5-pillar

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are FORZ's Key Strengths?

Specialized product line addressing muscle comfort and recovery.

  • High gross margin of 76.5% indicates efficient product cost structure.
  • Lean operational structure with 2 employees.
  • Positioned in the growing health-tech wearable market.

What Are FORZ's Weaknesses?

Significant negative profit margin of -4150.0% indicating substantial losses.

  • Extremely small operational scale with only two employees.
  • Market capitalization of $0.00B suggests very limited financial scale.
  • Unknown disclosure status on OTC market.

What Are the Key Risks for FORZ?

Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.

  • Insider selling — insiders were net sellers of roughly $2470.0B recently.
  • Significant negative profit margin of -4150.0% indicating substantial operational losses.
  • Limited operational scale with only two employees, potentially hindering growth and scalability.
  • Intense competition from well-capitalized companies in the health-tech and medical device sectors.
  • Challenges in securing additional funding to support operations and growth initiatives.
  • Regulatory and disclosure uncertainties associated with trading on the OTC Other tier.

What Threats Does FORZ Face?

  • Intense competition from established medical device companies and consumer electronics giants.
  • Potential for new entrants with superior technology or marketing.
  • Regulatory hurdles and compliance costs in the medical device industry.
  • Reliance on a single product line (WarmUp series).

What Are FORZ's Competitive Advantages?

  • Specialized focus on wearable back compression devices within the health-tech sector.
  • Proprietary design and technology of the WarmUp series products.
  • Brand recognition established through its specific product line.

What Does FORZ Do?

Forza Innovations Inc., originally incorporated as Genesys Industries, Inc. in 2014, underwent a significant rebranding in June 2021 to reflect its sharpened focus on the health-tech wearable performance market. Headquartered in San Diego, California, the company has strategically positioned itself within the burgeoning medical devices industry, specifically targeting solutions for muscle comfort and recovery. Its core product line, known as the WarmUp series, encompasses a range of wearable back compression devices. These innovative products, which include the J4 Sport, J4 X, and J4 Fitbelt, are engineered to provide targeted relief and support. The primary function of these devices is to assist users in relaxing, warming up, loosening, or alleviating stiff and sore muscles, catering to a diverse user base from athletes seeking pre-activity preparation to individuals experiencing everyday muscular discomfort. The company's evolution from its prior identity to Forza Innovations Inc. underscores a commitment to developing specialized, non-invasive health solutions. Despite its lean operational structure, with a reported two employees, Forza Innovations Inc. aims to carve out a distinct niche by offering accessible and user-friendly wearable technology. The company's strategy revolves around the utility and effectiveness of its WarmUp series, which addresses a common physiological need for muscle care. By focusing on wearable technology, Forza Innovations Inc. aligns with broader trends in healthcare towards preventative and self-managed wellness solutions. Its products are designed for direct consumer use, emphasizing ease of application and immediate benefits for muscle relaxation and recovery.

What Products and Services Does FORZ Offer?

  • Develops and sells health-tech wearable performance devices.
  • Offers the WarmUp series product line.
  • Manufactures wearable back compression devices.
  • Products include the J4 Sport, J4 X, and J4 Fitbelt.
  • Devices are designed to relax stiff and sore muscles.
  • Aids in warming up and loosening muscles.
  • Operates in the medical devices industry.

How Does FORZ Make Money?

  • Generates revenue through the direct sale of its WarmUp series wearable devices.
  • Focuses on the health-tech and muscle recovery consumer market.
  • Likely employs a direct-to-consumer sales model, potentially supplemented by retail partnerships.

What Industry Does FORZ Operate In?

Forza Innovations Inc. operates within the "Medical - Devices" industry, a sub-segment of the broader Healthcare sector. This industry is characterized by innovation in diagnostic, therapeutic, and assistive technologies. The global wearable medical device market, a key segment for Forza, is experiencing robust growth, driven by increasing health consciousness, the rise of chronic diseases, and technological advancements. These devices offer solutions for monitoring, prevention, and therapy, often empowering individuals with greater control over their health. Forza's WarmUp series positions it within the niche of therapeutic wearables focused on muscle recovery and pain relief. The competitive landscape includes established medical device manufacturers, specialized sports recovery brands, and emerging health-tech startups. Forza's challenge is to differentiate its back compression devices in a market where efficacy, comfort, and user experience are paramount, while also navigating regulatory considerations pertinent to medical devices.

Who Are FORZ's Key Customers?

  • Individuals seeking relief from stiff and sore muscles.
  • Athletes and fitness enthusiasts for warm-up and recovery.
  • Consumers interested in non-pharmacological muscle comfort solutions.
Model self-rating on this text: 66% (not a measure of the evidence) Updated: Jun 13, 2026

Research confidence

Low

Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.

  • ● Scoring coverage unknown
  • ● No usable price
  • ● No filing on record
  • ● No analyst coverage
F-Score 3/9

Financial Health

Forza Innovations Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.

Company Profile

Forza Innovations Inc. operates in the Medical - Devices industry within the Healthcare sector. It is headquartered in San Diego, US. The company is led by CEO Evan Schick. FORZ has traded publicly since 2019.

Net selling

Insider Activity

11 transactions · 0 purchases, 7 sales, 4 other transactions · 4 identified insiders · most recent available transactions. Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.

FORZ Financials

FORZ Latest News

No recent news available for FORZ.

FORZ Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for FORZ.

Price Targets

Wall Street price target analysis for FORZ.

FORZ MoonshotScore

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for FORZ; grades run from A+ (80-100) to F (below 30).

Leadership: Evan Schick

CEO

Evan Schick serves as the Chief Executive Officer of Forza Innovations Inc., leading the company's strategic direction and day-to-day operations. This suggests a hands-on leadership approach within a small, focused organization. His leadership is central to the company's efforts in developing and marketing its health-tech wearable performance products, particularly the WarmUp series of back compression devices.

Track Record: Under Evan Schick's leadership, Forza Innovations Inc. has focused on the development and commercialization of its WarmUp series, including the J4 Sport, J4 X, and J4 Fitbelt. A notable milestone was the company's rebranding from Genesys Industries, Inc. to Forza Innovations Inc. in June 2021, signifying a strategic pivot towards health-tech wearables. His management oversees the operations of the company with a small team, indicating a concentrated effort on product execution and market positioning within the medical devices industry.

FORZ OTC Market Information

Forza Innovations Inc. trades on the OTC market under the "OTC Other" tier. This tier is for companies that do not meet the disclosure requirements for OTCQX or OTCQB, or that do not qualify for the Pink Open Market. Companies in the OTC Other tier may not provide current or publicly available information to investors, which can lead to limited transparency. Unlike major exchanges like NYSE or NASDAQ, which have stringent listing standards regarding financial health, corporate governance, and disclosure, the OTC Other tier has minimal to no such requirements, making it a market with significantly less oversight.

  • OTC Tier: OTC Other
Liquidity: Given the "OTC Other" tier classification and a market capitalization of $0.00B, the liquidity for FORZ stock is likely very low. Trading volume may be sporadic, and the bid-ask spread could be wide, indicating a significant difference between the price buyers are willing to pay and sellers are willing to accept. This can make it difficult for investors to buy or sell shares quickly without impacting the price, posing a challenge for efficient trading and price discovery.
OTC Risk Factors:
  • Limited public information and disclosure due to "OTC Other" tier.
  • Potentially low trading volume and wide bid-ask spreads, impacting liquidity.
  • Increased susceptibility to fraud and manipulation due to reduced regulatory oversight.
  • Difficulty in obtaining reliable valuation metrics and financial data.
  • Higher volatility compared to exchange-listed securities.
Due Diligence Checklist:
  • Verify current financial statements and disclosures directly from the company, if available.
  • Research any past regulatory actions or enforcement against the company or management.
  • Assess the company's business operations and product viability independently.
  • Investigate management's background and track record beyond provided data.
  • Understand the specific risks associated with the "OTC Other" tier.
  • Seek independent legal and financial advice before considering investment.
Legitimacy Signals:
  • Incorporated in 2014, indicating a history of operation.
  • Headquartered in San Diego, California, a known hub for innovation.
  • Has a defined product line (WarmUp series) in a specific health-tech niche.

Forza Innovations Inc. Healthcare Stock: Key Questions Answered

What does Forza Innovations Inc. do?

Forza Innovations Inc. is a health-tech company based in San Diego, California, specializing in wearable performance devices. Its primary offering is the WarmUp series, which includes products like the J4 Sport, J4 X, and J4 Fitbelt.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated

MoonshotScore is not published for this security.

Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis